6 Item 1A. Risk Factors 54 Item 1B. Unresolved Staff Comments 105 Item 1C. Cybersecurity 105 Item 2. Properties 107 Item 3. Legal Proceedings 107 Item 4. Mine Safety Disclosures 107 PART II 108 Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 108 Item 6. [Reserved] 108 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 109 Item 7A. Quantitative and Qualitative Disclosures about Market Ris...
Q2 FY2026 — expected 2026-09-10
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-13 | 2025-12-31 | 0001193125-26-049397 | EDGAR | 132K words |
| 2025-02-19 | 2024-12-31 | 0000950170-25-022765 | EDGAR | — |
| 2024-02-29 | 2023-12-31 | 0000950170-24-022650 | EDGAR | — |
| 2023-02-17 | 2022-12-31 | 0000950170-23-003129 | EDGAR | — |
| 2022-03-01 | 2021-12-31 | 0000950170-22-002548 | EDGAR | — |
| 2021-02-24 | 2020-12-31 | 0001193125-21-054811 | EDGAR | — |
| 2020-02-26 | 2019-12-31 | 0001193125-20-049115 | EDGAR | — |
| 2019-02-28 | 2018-12-31 | 0001193125-19-057610 | EDGAR | — |
| 2018-03-15 | 2017-12-31 | 0001193125-18-084024 | EDGAR | — |
| 2017-03-16 | 2016-12-31 | 0001193125-17-084396 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-03 | 2025-09-30 | 0001193125-25-261667 | EDGAR | 73K words |
| 2025-08-11 | 2025-06-30 | 0000950170-25-106238 | EDGAR | — |
| 2025-05-12 | 2025-03-31 | 0000950170-25-069231 | EDGAR | — |
| 2024-11-05 | 2024-09-30 | 0000950170-24-121076 | EDGAR | — |
| 2024-08-06 | 2024-06-30 | 0000950170-24-091210 | EDGAR | — |
| 2024-05-08 | 2024-03-31 | 0000950170-24-055672 | EDGAR | — |
| 2023-11-02 | 2023-09-30 | 0000950170-23-057754 | EDGAR | — |
| 2023-08-02 | 2023-06-30 | 0000950170-23-036780 | EDGAR | — |
| 2023-05-04 | 2023-03-31 | 0000950170-23-017483 | EDGAR | — |
| 2022-11-03 | 2022-09-30 | 0000950170-22-021917 | EDGAR | — |
| 2022-08-04 | 2022-06-30 | 0000950170-22-014788 | EDGAR | — |
| 2022-05-05 | 2022-03-31 | 0000950170-22-007564 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-27 | 0001503802-26-000011 | EDGAR | 1K words |
| 2026-03-24 | 0001193125-26-120770 | EDGAR | — |
| 2026-03-03 | 0001503802-26-000006 | EDGAR | — |
| 2026-02-19 | 0001193125-26-059349 | EDGAR | — |
| 2026-02-12 | 0001193125-26-047670 | EDGAR | — |
| 2026-01-12 | 0001193125-26-009738 | EDGAR | — |
| 2025-11-03 | 0001193125-25-261663 | EDGAR | — |
| 2025-10-14 | 0001193125-25-239015 | EDGAR | — |
| 2025-10-08 | 0001193125-25-233983 | EDGAR | — |
| 2025-09-11 | 0001503802-25-000006 | EDGAR | — |
260 total filings indexed. 228 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001503802 |
| Ticker | KPTI |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.karyopharm.com |
| Listed | 2013-11-06 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report